Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Addict Biol. 2020 Apr 14;26(2):e12903. doi: 10.1111/adb.12903

Table 1.

Summary of recommendations and associated objective

Recommendation Objective
1. Refine language for basic and clinical phenotypes Bridge key constructs in alcohol research to facilitate translational research.
2. Biomarker Development Develop translatable, scalable biomarkers for pharmacotherapy and psychotherapy AUD treatments.
3. Conduct large scale longitudinal studies Link neurobiological substrates to clinically relevant outcomes.
4. Conduct generalizable clinical research Develop and refine clinical methods that increase external validity for AUD treatment.
5. Leverage resources Increase awareness in resources available to improve medication development.
6. Support translational and team-based training Promote scientific exchange between scientists across the translational spectrum and encourage team-based science.
7. Close the treatment gap Use currently available resources to benefit individuals with AUD.
8. Fill the evidence-based practice knowledge gap Improve communication between scientists and the public regarding evidence-based prevention and treatment strategies.